Related Experiment Video

Updated: Apr 30, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

21.6K

Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents

Claudia Patricia Rojas1, Rajasekhar Bodicharla, German Campuzano-Zuluaga

  • 11Department of Pathology, University of Miami, Holtz Children's Hospital, Miami, FL, USA.

Fetal and Pediatric Pathology
|April 24, 2014
PubMed

Insights

Diagnosing autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) overlap syndrome requires multiple tests, as clinical and biopsy findings can be misleading. Accurate diagnosis is crucial for appropriate treatment of these liver conditions.

Area of Science:

  • Pediatric Hepatology
  • Gastroenterology
  • Immunology

Background:

  • Autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) overlap syndrome (OS) present with similar clinical and histopathological features.
  • Distinct management strategies exist for AIH and PSC, necessitating accurate differentiation.

Purpose of the Study:

  • To analyze the clinical and histopathological characteristics of pediatric patients with AIH and PSC overlap syndrome.
  • To identify differentiating features between AIH and PSC in a pediatric cohort.

Main Methods:

  • Retrospective cross-sectional study of 34 pediatric patients diagnosed with AIH and PSC.
  • Review of clinical presentation, histopathology, and associated conditions like inflammatory bowel disease (IBD).

Main Results:

  • AIH showed a female predominance (74%), while PSC had a lower female representation (45%).
  • A trend towards higher frequency of Black patients in PSC/OS (55%) was observed compared to Caucasians (36%) and Hispanics (9%).
  • Inflammatory bowel disease (IBD) was present in 75% of PSC/OS cases. Plasma cells (42% in PSC) and concentric fibrosis (46% in AIH) were not specific diagnostic markers.

Conclusions:

  • Confirming and treating AIH and PSC requires integrating clinical history, laboratory results, imaging, and liver biopsy.
  • Liver biopsy is valuable for assessing disease severity and progression but insufficient for sole diagnosis of AIH or PSC.
Abstract

Keywords:
autoantibodiescholestasiscirrhosishepatitisliver biopsypediatric

More Related Videos

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

5.2K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

2.5K

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
30
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42